EP Patent

EP3037094A1 — Ophthalmic pharmaceutical composition

Assigned to Poifa Warszawa SA · Expires 2016-06-29 · 10y expired

What this patent protects

The present invention relates to an aqueous topical ophthalmic pharmaceutical composition comprising olopatatadine or pharmaceutically acceptable salts thereof, wherein the composition does not comprise a preservative.

USPTO Abstract

The present invention relates to an aqueous topical ophthalmic pharmaceutical composition comprising olopatatadine or pharmaceutically acceptable salts thereof, wherein the composition does not comprise a preservative.

Drugs covered by this patent

Patent Metadata

Patent number
EP3037094A1
Jurisdiction
EP
Classification
—
Expires
2016-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Poifa Warszawa SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.